Decatur Capital Management’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
Other funds holding CELG
OAG
PCM
Decatur Capital Management's CELG Position: Q1 2019 in Review
Decatur Capital Management sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 101,525 shares — an estimated $6.51M sold.
Decatur Capital Management first reported a position in CELG in Q3 2015 and held it in 7 quarters. The position peaked at $12.9M in Q4 2015. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.
- Decatur Capital Management reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
- Decatur Capital Management sold 101,525 Celgene Corp shares in Q1 2019, an estimated $6.51M.
- Decatur Capital Management first reported a position in Celgene Corp in Q3 2015 and held it in 7 quarters.
- Decatur Capital Management's Celgene Corp position peaked at $12.9M in Q4 2015.
- 1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.
Based on Decatur Capital Management's 13F filing for Q1 2019, filed 23 Apr 2019.